1
DIABETES MANAGEMENT NURSING EXAM –
INSULIN, PUMPS & DKA 2026-28 LATEST VERSION
Exam Structure
• Total Questions: 100
• Question Type: Multiple Choice (A–D)
• Time Allowed: 2 hours
• Passing Score: 75%
• Focus Areas:
o Types of diabetes and pathophysiology
o Insulin types, administration, and timing
o Insulin pumps and continuous glucose monitoring
o Diabetic ketoacidosis (DKA) recognition and management
o Hypoglycemia and hyperglycemia interventions
o Patient education, monitoring, and complication prevention
Exam Introduction
This exam evaluates nursing competency in diabetes management, focusing on insulin therapy, pump
management, and diabetic ketoacidosis. Questions simulate real-world clinical scenarios and are based on
evidence-based guidelines (ADA, CDC).
Instructions:
• Choose the single best answer for each question.
• Assume hospital policy aligns with current best practices.
• Each question includes answers and rationales for reinforcement.
,2
Question & Answer Format
• Question
• Answer Choices (A–D)
• Correct Answer
• Rationale
1. Type 1 diabetes is characterized by:
A. Insulin resistance
B. Autoimmune destruction of pancreatic beta cells
C. Obesity-related glucose intolerance
D. Gestational onset
Answer: B
Rationale: Type 1 diabetes results from autoimmune
destruction, leading to absolute insulin deficiency.
2. Rapid-acting insulin (e.g., lispro, aspart) should be
administered:
A. 30–60 minutes before meals
B. Immediately after meals
C. Once daily at bedtime
D. Only with long-acting insulin
,3
Answer: A
Rationale: Rapid-acting insulin covers postprandial glucose
elevations and is timed before meals.
3. Long-acting insulin (e.g., glargine) is primarily used:
A. To manage postprandial glucose
B. As basal insulin covering 24 hours
C. Only in DKA
D. Only for type 2 diabetes
Answer: B
Rationale: Long-acting insulin provides continuous basal
coverage to maintain fasting glucose.
4. The primary purpose of an insulin pump is to:
A. Replace oral hypoglycemics
B. Deliver continuous subcutaneous insulin for tight glucose
control
C. Treat hypoglycemia
D. Provide only bolus insulin
Answer: B
Rationale: Pumps deliver basal and bolus insulin, mimicking
physiologic insulin release.
, 4
5. Hypoglycemia is defined as:
A. Blood glucose <70 mg/dL
B. Blood glucose <100 mg/dL
C. Blood glucose >180 mg/dL
D. Blood glucose <40 mg/dL only
Answer: A
Rationale: Hypoglycemia is generally defined as glucose below
70 mg/dL and requires prompt intervention.
6. Early signs of hypoglycemia include:
A. Confusion, lethargy
B. Tremors, sweating, palpitations
C. Kussmaul respirations
D. Polyuria
Answer: B
Rationale: Sympathetic activation causes tremors, sweating,
and palpitations.
7. Rapid treatment of hypoglycemia in a conscious patient is:
A. Oral glucose or juice
B. IV insulin
DIABETES MANAGEMENT NURSING EXAM –
INSULIN, PUMPS & DKA 2026-28 LATEST VERSION
Exam Structure
• Total Questions: 100
• Question Type: Multiple Choice (A–D)
• Time Allowed: 2 hours
• Passing Score: 75%
• Focus Areas:
o Types of diabetes and pathophysiology
o Insulin types, administration, and timing
o Insulin pumps and continuous glucose monitoring
o Diabetic ketoacidosis (DKA) recognition and management
o Hypoglycemia and hyperglycemia interventions
o Patient education, monitoring, and complication prevention
Exam Introduction
This exam evaluates nursing competency in diabetes management, focusing on insulin therapy, pump
management, and diabetic ketoacidosis. Questions simulate real-world clinical scenarios and are based on
evidence-based guidelines (ADA, CDC).
Instructions:
• Choose the single best answer for each question.
• Assume hospital policy aligns with current best practices.
• Each question includes answers and rationales for reinforcement.
,2
Question & Answer Format
• Question
• Answer Choices (A–D)
• Correct Answer
• Rationale
1. Type 1 diabetes is characterized by:
A. Insulin resistance
B. Autoimmune destruction of pancreatic beta cells
C. Obesity-related glucose intolerance
D. Gestational onset
Answer: B
Rationale: Type 1 diabetes results from autoimmune
destruction, leading to absolute insulin deficiency.
2. Rapid-acting insulin (e.g., lispro, aspart) should be
administered:
A. 30–60 minutes before meals
B. Immediately after meals
C. Once daily at bedtime
D. Only with long-acting insulin
,3
Answer: A
Rationale: Rapid-acting insulin covers postprandial glucose
elevations and is timed before meals.
3. Long-acting insulin (e.g., glargine) is primarily used:
A. To manage postprandial glucose
B. As basal insulin covering 24 hours
C. Only in DKA
D. Only for type 2 diabetes
Answer: B
Rationale: Long-acting insulin provides continuous basal
coverage to maintain fasting glucose.
4. The primary purpose of an insulin pump is to:
A. Replace oral hypoglycemics
B. Deliver continuous subcutaneous insulin for tight glucose
control
C. Treat hypoglycemia
D. Provide only bolus insulin
Answer: B
Rationale: Pumps deliver basal and bolus insulin, mimicking
physiologic insulin release.
, 4
5. Hypoglycemia is defined as:
A. Blood glucose <70 mg/dL
B. Blood glucose <100 mg/dL
C. Blood glucose >180 mg/dL
D. Blood glucose <40 mg/dL only
Answer: A
Rationale: Hypoglycemia is generally defined as glucose below
70 mg/dL and requires prompt intervention.
6. Early signs of hypoglycemia include:
A. Confusion, lethargy
B. Tremors, sweating, palpitations
C. Kussmaul respirations
D. Polyuria
Answer: B
Rationale: Sympathetic activation causes tremors, sweating,
and palpitations.
7. Rapid treatment of hypoglycemia in a conscious patient is:
A. Oral glucose or juice
B. IV insulin
